In conclusion, our substantial body of work focusing on the NSUN2/YBX1/m5C‐ENO1 signaling axis may offer valuable insights pertaining to the pathogenesis and identification of epigenetic–immune targets in CRC. This evidence concerns the gene YBX1 and colorectal carcinoma.